A doença renal policística autossômica dominante (DRPAD) felina é caracterizada pela presença de múltiplos cistos localizados em parênquima renal e, ocasionalmente, hepáticoe pancreático, sendo uma importante causa de doença renal crônica terminal. Ela é considerada a enfermidade congênita hereditária mais prevalente dos gatos domésticos, porém, os dados epidemiológicos eclínicos existentes no Brasil são escassos, o que torna o seu controle mais difícil no país. Da mesma forma, a DRPAD em humanos constitui-se na doença renal monogênica mais comum, acometendo 1 em cada 400 a 1.000 indivíduos, com curso clínico muito semelhante a doença em gatos.No presente estudo, 252 felinos da raça Persa e mestiços de Persa do Estado de São Paulo foram avaliados através de teste genético para DRPAD. Os resultados indicaram uma prevalência de apenas 6,35% de gatos portadores da mutação para DRPAD em heterozigose, valor abaixo dos índices registrados em outros países. Do total de animais, uma coorte de 82 felinos da região metropolitana de São Paulo foi selecionada para realização de exames físico, laboratoriais, imagenológicos e genéticos. Estes animais foram separados em dois grupos de acordo com a presença (n=12) ou ausência (n=70) de alterações ultrassonográficas sugestivas de doença renal policística.A sensibilidade e a especificidade entre o teste molecular e o exame ultrassonográfico para DRPAD nos animais estudados foram ambas de 100%. Os animais com alterações genéticas e ultrassonográficas indicativas de doença renal policística autossômica dominante apresentaram aumento significativo no valor de cálcio total sérico, fração de excreção urinária de cálcio e de sódio(p=0,0219; p=0,0275; p=0,0032, respectivamente). Os demais parâmetros clínicos e laboratoriais não diferiram entre os dois grupos de animais. O exame ecocardiográfico revelou que casos de hipertrofia miocárdica foram mais frequente entre os animais positivos para DRPAD (p=0,0001). Dessa forma, é possível concluir que exames de triagem ultrassonográfica e/ou molecular devem ser utilizados para o diagnóstico de animais com DRPAD, visto que, alterações clínicas e laboratoriais sã o tardias. Exames eletro e ecocardiográficos devem ser rotineiramente realizados nos felinos císticos. Ainda, a caracterização clínica da DRPAD em gatos ressalta não apenas sua grande importância para medicina felina, mas também para a comunidade médica devido à correlação com a doença humana, representando um modelo ortólogo espontâneo, em animal de porte médio, para o estudo dessa enfermidade e validação de novos procedimentos terapêuticos. / Autosomal dominant polycystic kidney disease (ADPKD) in feline is characterized by the presence of multiple cists located in the renal parenchyma and occasionally, in liver and pancreas, and is an important cause of terminal chronic renal disease. It is considered worldwide as the most prevalent congenital illness in domestic cats. However, in Brazil the epidemiological and clinical data are barely existent, which difficultythe control of the disease. In the same way, the human ADPKD is the most common monogenic kidney disease. It affects 1 in every 400 to 1000 individuals, with a clinical course very similar to the disease in feline. In this research, 252 Persians and crossbreed cats from São Paulo state were assessed through the genetic test for ADPKD. The results indicated a prevalence of only 6.35% of cats carring the mutation for ADPKD in heterozygosis. This value is below the indexes reported in other countries. A cohort of 82 cats was selected in the metropolitan region of São Paulo to perform physical, laboratory, imaging and genetic tests. These animals were divided into two groups according to the presence (n = 12) or absence (n = 70) of ultrasound changes suggestive of polycystic kidney disease. The sensitivity and specificity between molecular tests and ultrasonography exam for ADPKD in the sample were both 100%. The animals with ultrasonography and genetic modifications, indicatives of ADPKD, presented a significant increase in the amount of total serum calcium, urinary fractional excretion of calcium and sodium(p=0,0219; p=0,0275; p=0,0032, respectively). Other clinical and laboratory parameters did not differ between the two groups of animals with and without the disease. Echocardiographic examination revealed that cases of myocardial hypertrophy were more frequent among animals positive for ADPKD (p = 0.0001). In conclusion, ultrasound exams and/ or molecular screening should be used to diagnostic animals with ADPKD, since the clinical and laboratory abnormalities are late. Electrocardiography and echocardiography examinations should be routinely performed in cystic cats. Still, the clinical characterization of ADPKD in cats not only highlights its importance to feline medicine, but also for the medical community due to the correlation with human disease, as an ortholog spontaneous model for the study of this disease.

A doença renal policística autossômica dominante (DRPAD) felina é caracterizada pela presença de múltiplos cistos localizados em parênquima renal e, ocasionalmente, hepáticoe pancreático, sendo uma importante causa de doença renal crônica terminal. Ela é considerada a enfermidade congênita hereditária mais prevalente dos gatos domésticos, porém, os dados epidemiológicos eclínicos existentes no Brasil são escassos, o que torna o seu controle mais difícil no país. Da mesma forma, a DRPAD em humanos constitui-se na doença renal monogênica mais comum, acometendo 1 em cada 400 a 1.000 indivíduos, com curso clínico muito semelhante a doença em gatos.No presente estudo, 252 felinos da raça Persa e mestiços de Persa do Estado de São Paulo foram avaliados através de teste genético para DRPAD. Os resultados indicaram uma prevalência de apenas 6,35% de gatos portadores da mutação para DRPAD em heterozigose, valor abaixo dos índices registrados em outros países. Do total de animais, uma coorte de 82 felinos da região metropolitana de São Paulo foi selecionada para realização de exames físico, laboratoriais, imagenológicos e genéticos. Estes animais foram separados em dois grupos de acordo com a presença (n=12) ou ausência (n=70) de alterações ultrassonográficas sugestivas de doença renal policística.A sensibilidade e a especificidade entre o teste molecular e o exame ultrassonográfico para DRPAD nos animais estudados foram ambas de 100%. Os animais com alterações genéticas e ultrassonográficas indicativas de doença renal policística autossômica dominante apresentaram aumento significativo no valor de cálcio total sérico, fração de excreção urinária de cálcio e de sódio(p=0,0219; p=0,0275; p=0,0032, respectivamente). Os demais parâmetros clínicos e laboratoriais não diferiram entre os dois grupos de animais. O exame ecocardiográfico revelou que casos de hipertrofia miocárdica foram mais frequente entre os animais positivos para DRPAD (p=0,0001). Dessa forma, é possível concluir que exames de triagem ultrassonográfica e/ou molecular devem ser utilizados para o diagnóstico de animais com DRPAD, visto que, alterações clínicas e laboratoriais sã o tardias. Exames eletro e ecocardiográficos devem ser rotineiramente realizados nos felinos císticos. Ainda, a caracterização clínica da DRPAD em gatos ressalta não apenas sua grande importância para medicina felina, mas também para a comunidade médica devido à correlação com a doença humana, representando um modelo ortólogo espontâneo, em animal de porte médio, para o estudo dessa enfermidade e validação de novos procedimentos terapêuticos. / Autosomal dominant polycystic kidney disease (ADPKD) in feline is characterized by the presence of multiple cists located in the renal parenchyma and occasionally, in liver and pancreas, and is an important cause of terminal chronic renal disease. It is considered worldwide as the most prevalent congenital illness in domestic cats. However, in Brazil the epidemiological and clinical data are barely existent, which difficultythe control of the disease. In the same way, the human ADPKD is the most common monogenic kidney disease. It affects 1 in every 400 to 1000 individuals, with a clinical course very similar to the disease in feline. In this research, 252 Persians and crossbreed cats from São Paulo state were assessed through the genetic test for ADPKD. The results indicated a prevalence of only 6.35% of cats carring the mutation for ADPKD in heterozygosis. This value is below the indexes reported in other countries. A cohort of 82 cats was selected in the metropolitan region of São Paulo to perform physical, laboratory, imaging and genetic tests. These animals were divided into two groups according to the presence (n = 12) or absence (n = 70) of ultrasound changes suggestive of polycystic kidney disease. The sensitivity and specificity between molecular tests and ultrasonography exam for ADPKD in the sample were both 100%. The animals with ultrasonography and genetic modifications, indicatives of ADPKD, presented a significant increase in the amount of total serum calcium, urinary fractional excretion of calcium and sodium(p=0,0219; p=0,0275; p=0,0032, respectively). Other clinical and laboratory parameters did not differ between the two groups of animals with and without the disease. Echocardiographic examination revealed that cases of myocardial hypertrophy were more frequent among animals positive for ADPKD (p = 0.0001). In conclusion, ultrasound exams and/ or molecular screening should be used to diagnostic animals with ADPKD, since the clinical and laboratory abnormalities are late. Electrocardiography and echocardiography examinations should be routinely performed in cystic cats. Still, the clinical characterization of ADPKD in cats not only highlights its importance to feline medicine, but also for the medical community due to the correlation with human disease, as an ortholog spontaneous model for the study of this disease.

Thesis (Ph.D.)--University of Alabama at Birmingham, 2007. / Title from PDF title page (viewed on Feb. 19, 2010). Includes bibliographical references.

No description available.

Thesis (Ph. D.)--Case Western Reserve University, 2005. / [School of Medicine] Department of Physiology and Biophysics. Includes bibliographical references. Available online via OhioLINK's ETD Center.

Thesis (M.S.)--University of Alabama at Birmingham, 2006. / Title from first page of PDF file (viewed on June 30, 2007). Includes bibliographical references (p. 69-73).

No description available.

Background: Complications related to peritoneal dialysis (PD) in patients with autosomal-dominant polycystic kidney disease (ADPKD), including intraperitoneal rupture of renal cyst, hernia, membrane failure and peritonitis, have been reported. However, long-term clinical outcomes of ADPKD patients on PD remain unclear. We performed this meta-analysis to assess the risks of death, technique failure and peritonitis in ADPKD patients on PD. Methods: A systematic review was conducted using MEDLINE, EMBASE and Cochrane databases from inception to October 2017 to identify studies that evaluated the outcomes of ADPKD patients on PD, including the risks of death, technique failure and peritonitis. Non-ADPKD patients on PD were used as controls. Effect estimates from the individual study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results: Twelve cohort studies with a total of 14 673 patients on PD (931 ADPKD and 13 742 non-ADPKD patients) were enrolled. Compared with non-ADPKD status, ADPKD was associated with significantly decreased mortality risk with pooled odds ratio (OR) of 0.68 (95% confidence interval (CI), 0.53–0.86; I 2 = 0). There were no associations of ADPKD with the risks of technique failure of PD and peritonitis with pooled OR of 0.93 (95% CI, 0.79–1.10; I 2 = 0) and 0.88 (95% CI, 0.75–1.05; I 2 = 0), respectively. We found no publication bias as assessed by Egger's regression asymmetry test, with P = 0.90, 0.28 and 0.60 for the risks of mortality, technique failure and peritonitis in ADPKD patients on PD, respectively. Conclusion: Compared with non-ADPKD patients on PD, our study demonstrates that ADPKD patients on PD have 0.68-fold decreased mortality risk. There are no associations of ADPKD status with the risks of technique failure or peritonitis.

Polycystic kidney disease is an inherited degenerative disease in which the uriniferous tubules are replaced by expanding fluid-filled cysts that ultimately destroy organ function. Autosomal dominant polycystic kidney disease (ADPKD) is the most common form, afflicting approximately 1 in 1,000 people. It primarily is caused by mutations in the transmembrane proteins Polycystin-1 (PKD1) and Polycystin-2 (PKD2). The most proximal effects of polycystin mutations leading to cyst formation are not known, but pro-proliferative signaling must be involved for the tubule epithelial cells to increase in number over time. The stress-activated mitogen-activated protein kinase (MAPK) pathway c-Jun N-terminal kinase (JNK) promotes proliferation in specific contexts and is activated in acute and chronic kidney disease. Previous work found evidence of JNK activation in cystic tissues (Le et al., 2005) and others showed that JNK signaling is activated by aberrant expression of PKD1 and PKD2 in cell culture (Arnould et al., 1998; Arnould et al., 1999; Parnell et al., 2002; Yu et al., 2010) but the contribution of JNK signaling to cystic disease in vivo has not been investigated. This body of work describes the use of conditional and germline deletion of Pkd2, Jnk1 and Jnk2 to model ADPKD and JNK signaling inhibition in juvenile and adult mice. Immunoblots and histological staining were used to measure JNK activation and evaluate the effect of JNK deletion on cystic disease. Results show that Pkd2 deletion activated JNK signaling in juvenile and adult mice. Reduction of JNK activity significantly reduced cystic burden in kidneys of juvenile Pkd2 mutant mice. This correlated with reduced tubule cell proliferation and reduced kidney fibrosis. The improvement in cystic phenotype was driven primarily by Jnk1 deletion rather than Jnk2. JNK signaling inhibition in adult Pkd2 mutants significantly reduced liver cysts when mice were aged six months. JNK inhibition reduces the severity of cystic disease caused by the loss of Pkd2 suggesting that the JNK pathway should be explored as a potential therapeutic target for ADPKD.

Polycystic kidney disease is a severe genetic disease occurring in both adult and pediatric patients. The basic characteristic of this disease is the development and progressive enlargement of renal cysts gradually replacing functional kidney tissue. This leads to renal failure in many patients. However, renal cysts may also occur in a number of other diseases, including multisystem syndromes. This complicates differential diagnosis in some patients. In our study, we first focused on the diagnosis and characterization of genotypic-phenotypic relationships in patients with polycystic disease arising in childhood, later we extended our study to adult patients and patients with unclear clinical diagnosis. At the same time, we expanded the portfolio of analyzed disorders to a number of diseases in which the phenotype of polycystic kidneys may occur, and noncystic diseases as well. During our project, massive parallel sequencing was used to analyze 149 patients - 128 with cystic and 21 with noncystic clinically diagnosed nephropathies. At the same time, the findings were verified by Sanger sequencing in 176 relatives of our probands. Mutation detection reached 59% in cystic patients, and 43% in non-cystic patients, respectively. In many patients, molecular genetic analysis revealed a different etiology...